Rubra Medicaments Share Price

Rubra Medicaments

CMP as on22-Oct-21 12:29

₹ 3.20
-0.16 -4.76%

Open

₹ 3.20

Turnover (lac)

Prev. Close

₹ 3.36

Day's Vol (shares)

₹ 1,920

Day's Range

₹ 3.20
₹ 3.20

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Aug-2021 - -
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve 1. Standalone Unaudited Financial Results along with limited review report of the Company for the quarter ended June 30, 2021. 2. To fix the dates of Book Closure for Annual General Meeting. 3. To decide the time, venue and date of Annual General Meeting. To Consider and approved Unaudited Standalone Financial Results along with limited review report for the quarter ended June 30, 2021 (As Per BSE Announcement dated on 13.08.2021)
Board Meeting - 15-Jun-2021 - -
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/06/2021 ,inter alia, to consider and approve the Standalone Audited Financial Results of the Company for the quarter and year ended March 31, 2021 To considered and approved the Audited Standalone Financial Results for the year ended March 31, 2021 (As per BSE Announcement Dated on 29/06/2021)
Board Meeting - 07-Apr-2021 - -
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2021 ,inter alia, to consider and approve appointment of Independent Director
Board Meeting - 01-Feb-2021 - -
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Standalone unaudited Financial Result along with limited review report for the Quarter ended December 31, 2020. To considered and approved the Unaudited Standalone Financial Results for the quarter ended December 31, 2020 along with the Limited Review Report. (As Per BSE Announcement dated on 12.02.2021)
Board Meeting - 02-Nov-2020 - -
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve RUBRA MEDICAMENTS LTD. has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020,inter alia, to consider and approve adoption of standalone unaudited Financial Result along with limited review report for the Quarter ended September 30, 2020.
Open ZERO Brokerage Demat Account